[Federal Register Volume 85, Number 12 (Friday, January 17, 2020)]
[Notices]
[Pages 3052-3053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00733]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2017-N-2495]
Request for Nominations for Voting Members on a Public Advisory
Committee; Technical Electronic Product Radiation Safety Standards
Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for members to serve on the Technical Electronic Product
Radiation Safety Standards Committee (TEPRSSC) in the Center for
Devices and Radiological Health. Nominations will be accepted for
current and upcoming vacancies effective with this notice.
FDA seeks to include the views of women and men, members of all
racial and ethnic groups, and individuals with and without disabilities
on its advisory committees and, therefore, encourages nominations of
appropriately qualified candidates from these groups.
DATES: Nominations received on or before March 17, 2020, will be given
first consideration for membership on TEPRSSC. Nominations received
after March 17, 2020, will be considered for nomination to the
committee as later vacancies occur.
ADDRESSES: All nominations for membership should be sent electronically
by accessing FDA's Advisory Committee Membership Nomination Portal at
https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or
by mail to Advisory Committee Oversight and Management Staff, Food and
Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103,
Silver Spring, MD 20993-0002. Information about becoming a member on an
FDA advisory committee can also be obtained by visiting FDA's website
at https://www.fda.gov/AdvisoryCommittees/default.htm.
[[Page 3053]]
FOR FURTHER INFORMATION CONTACT: Patricio G. Garcia, Division of
Management Services, Center for Devices and Radiological Health, Food
and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5216,
Silver Spring, MD 20993-0002, 301-796-6875, email:
[email protected].
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting
members on TEPRSSC that include three general public representatives.
I. General Description of the Committee's Duties
The committee provides advice and consultation to the Commissioner
of Food and Drugs (Commissioner) on the technical feasibility,
reasonableness, and practicability of performance standards for
electronic products to control the emission of radiation from such
products, and may recommend electronic product radiation safety
standards to the Commissioner for consideration.
II. Criteria for Voting Members
The committee consists of a core of 15 voting members including the
Chair. Members and the Chair are selected by the Commissioner or
designee from among authorities knowledgeable in the fields of science
or engineering, applicable to electronic product radiation safety.
Members will be invited to serve for overlapping terms of up to 4
years. Terms of more than 2 years are contingent upon the renewal of
the committee by appropriate action prior to its expiration.
III. Nomination Procedures
Any interested person may nominate one or more qualified
individuals for membership on the committee. Self-nominations are also
accepted. Nominations must include a current, complete
r[eacute]sum[eacute] or curriculum vitae for each nominee, including
current business address and/or home address, telephone number, and
email address if available and a signed copy of the Acknowledgement and
Consent form available at the FDA Advisory Nomination Portal (see
ADDRESSES). Nominations must also specify the advisory committee for
which the nominee is recommended. Nominations must also acknowledge
that the nominee is aware of the nomination unless self-nominated. FDA
will ask potential candidates to provide detailed information
concerning such matters related to financial holdings, employment, and
research grants and/or contracts to permit evaluation of possible
sources of conflicts of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: January 10, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-00733 Filed 1-16-20; 8:45 am]
BILLING CODE 4164-01-P